Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

被引:0
|
作者
Lin, Chieh-Hsin [1 ,2 ]
Chang, Yue-Cune [3 ]
Lane, Hsien-Yuan [1 ,4 ]
机构
[1] China Med Univ, Inst Clin Med Sci, Taichung, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Psychiat, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[3] Tamkang Univ, Dept Math, Taipei, Taiwan
[4] China Med Univ Hosp, Dept Psychiat, 2 Yuh Der Rd, Taichung 404, Taiwan
关键词
N-methyl-D-aspartate; refractory schizophrenia; D-amino acids oxidase (DAAO) inhibitor; sodium benzoate; clinical trial;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PM405
引用
收藏
页码:196 / 196
页数:1
相关论文
共 50 条
  • [41] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH TREATMENT-RESISTANT PARTIAL SEIZURES
    LOISEAU, P
    YUEN, AWC
    DUCHE, B
    MENAGER, T
    ARNEBES, MC
    [J]. EPILEPSY RESEARCH, 1990, 7 (02) : 136 - 145
  • [42] Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chieh-Hsin
    Lin, Ching-Hua
    Chang, Yue-Cune
    Huang, Yu-Jhen
    Chen, Po-Wei
    Yang, Hui-Ting
    Lane, Hsien-Yuan
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 84 (06) : 422 - 432
  • [43] Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Shibre, Teshome
    Alem, Atalay
    Abdulahi, Abdulreshid
    Araya, Mesfin
    Beyero, Teferra
    Medhin, Girmay
    Deyassa, Negusse
    Negash, Alemayehu
    Nigatu, Alemayehu
    Kebede, Derege
    Fekadu, Abebaw
    [J]. SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 846 - 851
  • [44] Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
    Ghanizadeh, Ahmad
    Rezaee, Zahra
    Dehbozorgi, Sara
    Berk, Michael
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY RESEARCH, 2014, 219 (03) : 431 - 435
  • [45] Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Josiassen, RC
    Joseph, A
    Kohegyi, E
    Stokes, S
    Dadvand, M
    Paing, WW
    Shaughnessy, RA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01): : 130 - 136
  • [46] Double-blind, placebo-controlled, cross-over trial of allopurinol as add-on therapy in childhood refractory epilepsy
    Coppola, G
    Pascotto, A
    [J]. BRAIN & DEVELOPMENT, 1996, 18 (01): : 50 - 52
  • [47] Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia A Randomized, Double-Blind, Placebo-Controlled Study
    Hosseininasab, Masumeh
    Zarghami, Mehran
    Mazhari, Shahrzad
    Salehifar, Ebrahim
    Moosazadeh, Mahmood
    Fariborzifar, Arghavan
    Babaeirad, Sareh
    Hendouei, Narjes
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (01) : 25 - 30
  • [48] Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Wang, Xiujuan
    Zhao, Jingyuan
    Hu, YunQing
    Jiao, Zhiqiang
    Lu, Yanli
    Ding, Minli
    Kou, Yanna
    Li, Benliang
    Meng, Fancui
    Zhao, Hongzu
    Li, Hong
    Li, Wenqiang
    Yang, Yongfeng
    Lv, Luxian
    [J]. PSYCHIATRY RESEARCH, 2018, 269 : 271 - 277
  • [49] Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
    Zwiep, J. C.
    Bet, P. M.
    Rhebergen, D.
    Nurmohamed, M. T.
    Vinkers, C. H.
    Penninx, B. W. J. H.
    Milaneschi, Y.
    Lamers, F.
    [J]. BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2023, 27
  • [50] Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures
    Wu, Xun-Yi
    Hong, Zhen
    Wu, Xun
    Wu, Li-Wen
    Wang, Xue-Feng
    Zhou, Dong
    Zhao, Zhong-Xin
    Lv, Chuan-Zhen
    [J]. EPILEPSIA, 2009, 50 (03) : 398 - 405